Chimeric Enzyme Targeting for Lipid Biosynthesis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods fail to efficiently engineer novel enzymes to target specific subdomains of the endoplasmic reticulum (ER) in plants for the production of desired lipids, such as short-chain wax esters, which are essential for high-grade lubricants and renewable energy sources, due to challenges in localizing enzymes correctly for concerted action.

Innovation Solution

The method involves creating chimeric proteins by fusing fatty acyl-CoA reductase and wax ester synthase with a heterologous polypeptide targeting them to the same subdomain of the ER, such as oleosin, using recombinant DNA techniques, to enhance the production of short-chain wax esters in non-human eukaryotic organisms like yeast and plants.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If novel enzymes are introduced into plants for lipid biosynthesis, then new lipid products can be produced, but the enzymes may be incompatible with incorporation into cellular membranes or may interfere with normal fatty acid flux

Engineering Contradiction:
Improveproduction of new lipid productsVSAvoidenzyme incorporation and normal metabolic flux
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent uses oleosin polypeptides as intermediary targeting signals to direct novel enzymes (fatty acyl-CoA reductase and wax ester synthetase) to specific subdomains of the endoplasmic reticulum. This intermediary targeting mechanism allows the foreign enzymes to be properly localized and integrated into the plant cellular membrane system without disrupting normal metabolic pathways, thereby resolving the contradiction between producing new lipid products and maintaining enzyme compatibility with cellular membranes.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If enzymes are targeted to specific subdomains of the ER, then metabolic efficiency is enhanced, but the complexity of protein engineering increases

Engineering Contradiction:
Improvemetabolic efficiency of lipid synthesisVSAvoidprotein engineering complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent combines the novel metabolic enzymes (fatty acyl-CoA reductase and wax ester synthetase) with the oleosin targeting polypeptide into single chimeric fusion proteins. This merging of functional domains into one construct simplifies the protein engineering process compared to attempting to engineer separate targeting and catalytic domains, while still achieving the desired subdomain-specific localization and enhanced metabolic efficiency for lipid synthesis.

Inventive Principle:
Principle #5Merging (Combining)

Data Source

PatentEP2491119B1Methods and means to alter lipid biosynthesis by targeting multiple enzymes to suborganelle domains
Publication Date: 2016.06.08 BAYER CROPSCIENCE NV
  • EP2491119B1 patent drawingFigure 1
  • EP2491119B1 patent drawingFigure 2A~2F
  • EP2491119B1 patent drawingFigure 3

AI summary

Methods and means are provided to alter lipid biosynthesis in eukaryotic organisms by targeting at least two different polypeptides involved in fatty acid or lipid metabolism towards a similar or the same subdomain of an organelle, such as the endoplasmatic reticulum (ER), through fusion of the polypeptides with a similar or the same heterologous polypeptide targeting the chimeric fusion polypeptide to the mentioned subdomain.